It can take generic makers years to get ready to produce a drug, and they need to have a sense of the potential market in order to commit to investing in production. So, in the meantime, Gilead will aim to to ship “sufficient volumes” of lenacaprivir to low-income countries as soon as it has regulatory…
There is a certain irony to the fact that the most consequential role Stormy Daniels, the adult entertainer at the heart of the Trump criminal trial, may ever play is taking place off screen. There are no cameras allowed in the courtroom where she is a crucial witness, as she tells her story of her…
A landmark antitrust trial against Google concluded on Friday after a federal judge heard final arguments, setting the stage for a ruling that could fundamentally shift the tech industry’s power. “The importance and significance of this case is not lost on me, not only for Google but for the public,” Judge Amit P. Mehta said…
On Tuesday, Google’s employees gathered for an all-hands meeting named T.G.I.F. These companywide meetings are rarely held on Fridays these days, but the name has stuck. Executives shared highlights from a recent earnings report and cloud-computing conference, and warned workers against taking disruptive actions in the wake of internal protests against a cloud-computing contract with…
The biggest U.S. challenge so far to the vast power of today’s tech giants has reached its climax. On Thursday and Friday, lawyers for the Justice Department, state attorneys general and Google will deliver their final arguments in a yearslong case — U.S. et al. v. Google — over whether the tech giant broke federal…
One of the few treatments the Food and Drug Administration has approved for amyotrophic lateral sclerosis has failed a large clinical trial, and its manufacturer said Friday that it was considering whether to withdraw it from the market. The medication, called Relyvrio, was approved less than two years ago, despite questions about its effectiveness in…
